36746222|t|DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease.
36746222|a|Neuromelanin (NM) in dopaminergic neurons of human substantia nigra (SN) has a melanic component that consists of pheomelanin and eumelanin moieties and has been proposed as a key factor contributing to dopaminergic neuron vulnerability in Parkinson's disease (PD). While eumelanin is considered as an antioxidant, pheomelanin and related oxidative stress are associated with compromised drug and metal ion binding and melanoma risk. Using postmortem SN from patients with PD or Alzheimer's disease (AD) and unaffected controls, we identified increased L-3,4-dihydroxyphenylalanine (DOPA) pheomelanin and increased ratios of dopamine (DA) pheomelanin markers to DA in PD SN compared to controls. Eumelanins derived from both DOPA and DA were reduced in PD group. In addition, we report an increase in DOPA pheomelanin relative to DA pheomelanin in PD SN. In AD SN, we observed unaltered melanin markers despite reduced DOPA compared to controls. Furthermore, synthetic DOPA pheomelanin induced neuronal cell death in vitro while synthetic DOPA eumelanin showed no significant effect on cell viability. Our findings provide insights into the different roles of pheomelanin and eumelanin in PD pathophysiology. We anticipate our study will lead to further investigations on pheomelanin and eumelanin individually as biomarkers and possibly therapeutic targets for PD.
36746222	0	16	DOPA pheomelanin	Chemical	-
36746222	40	52	neuromelanin	Chemical	MESH:C014121
36746222	56	75	Parkinson's disease	Disease	MESH:D010300
36746222	77	89	Neuromelanin	Chemical	MESH:C014121
36746222	91	93	NM	Chemical	MESH:C014121
36746222	122	127	human	Species	9606
36746222	191	202	pheomelanin	Chemical	MESH:C018362
36746222	207	216	eumelanin	Chemical	MESH:C041877
36746222	317	336	Parkinson's disease	Disease	MESH:D010300
36746222	338	340	PD	Disease	MESH:D010300
36746222	349	358	eumelanin	Chemical	MESH:C041877
36746222	392	403	pheomelanin	Chemical	MESH:C018362
36746222	474	479	metal	Chemical	MESH:D008670
36746222	496	504	melanoma	Disease	MESH:D008545
36746222	536	544	patients	Species	9606
36746222	550	552	PD	Disease	MESH:D010300
36746222	556	575	Alzheimer's disease	Disease	MESH:D000544
36746222	577	579	AD	Disease	MESH:D000544
36746222	630	677	L-3,4-dihydroxyphenylalanine (DOPA) pheomelanin	Chemical	-
36746222	702	710	dopamine	Chemical	MESH:D004298
36746222	712	714	DA	Chemical	MESH:D004298
36746222	716	727	pheomelanin	Chemical	MESH:C018362
36746222	739	741	DA	Chemical	MESH:D004298
36746222	745	750	PD SN	Disease	MESH:D010300
36746222	773	783	Eumelanins	Chemical	MESH:C041877
36746222	811	813	DA	Chemical	MESH:D004298
36746222	830	832	PD	Disease	MESH:D010300
36746222	878	894	DOPA pheomelanin	Chemical	-
36746222	907	921	DA pheomelanin	Chemical	-
36746222	925	930	PD SN	Disease	MESH:D010300
36746222	935	937	AD	Disease	MESH:D000544
36746222	964	971	melanin	Chemical	MESH:D008543
36746222	1046	1062	DOPA pheomelanin	Chemical	-
36746222	1116	1130	DOPA eumelanin	Chemical	-
36746222	1237	1248	pheomelanin	Chemical	MESH:C018362
36746222	1253	1262	eumelanin	Chemical	MESH:C041877
36746222	1266	1268	PD	Disease	MESH:D010300
36746222	1349	1360	pheomelanin	Chemical	MESH:C018362
36746222	1365	1374	eumelanin	Chemical	MESH:C041877
36746222	1439	1441	PD	Disease	MESH:D010300
36746222	Negative_Correlation	MESH:C041877	MESH:D010300
36746222	Association	MESH:C018362	MESH:D008545
36746222	Association	MESH:C018362	MESH:D010300
36746222	Association	MESH:C014121	MESH:D010300
36746222	Association	MESH:D004298	MESH:D010300
36746222	Association	MESH:C018362	MESH:D008670
36746222	Association	MESH:C014121	MESH:C018362

